Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

September 1, 2027

Conditions

Post Traumatic Headache

Interventions

DRUG

Eptinezumab

Eptinezumab 300mg IV

OTHER

Placebo

Control - placebo IV

Trial Locations (1)

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors

lead

Sunnybrook Health Sciences Centre

OTHER